Treatment of multiple myeloma in the targeted therapy era.
about
Salvage second hematopoietic cell transplantation in myelomaBone marrow microenvironment in myelomagenesis: its potential role in early diagnosis.The role of bortezomib, thalidomide and lenalidomide in the management of multiple myeloma: an overview of clinical and economic information.Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.
P2860
Treatment of multiple myeloma in the targeted therapy era.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treatment of multiple myeloma in the targeted therapy era.
@en
Treatment of multiple myeloma in the targeted therapy era.
@nl
type
label
Treatment of multiple myeloma in the targeted therapy era.
@en
Treatment of multiple myeloma in the targeted therapy era.
@nl
prefLabel
Treatment of multiple myeloma in the targeted therapy era.
@en
Treatment of multiple myeloma in the targeted therapy era.
@nl
P2860
P356
P1476
Treatment of multiple myeloma in the targeted therapy era
@en
P2093
Gerald M Higa
Manish Sharma
P2860
P304
P356
10.1345/APH.1L428
P407
P50
P577
2009-02-03T00:00:00Z